Search by Drug Name or NDC

    NDC 68382-0775-77 Methotrexate 2.5 mg/1 Details

    Methotrexate 2.5 mg/1

    Methotrexate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is METHOTREXATE.

    Product Information

    NDC 68382-0775
    Product ID 68382-775_12e61f0c-901b-4891-9a52-0cf78ebe64b6
    Associated GPIs 21300050100310
    GCN Sequence Number 036872
    GCN Sequence Number Description methotrexate sodium TABLET 2.5 MG ORAL
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 38489
    HICL Sequence Number 003905
    HICL Sequence Number Description METHOTREXATE SODIUM
    Brand/Generic Generic
    Proprietary Name Methotrexate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Methotrexate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/1
    Substance Name METHOTREXATE
    Labeler Name Zydus Pharmaceuticals USA Inc.
    Pharmaceutical Class Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207812
    Listing Certified Through 2024-12-31

    Package

    NDC 68382-0775-77 (68382077577)

    NDC Package Code 68382-775-77
    Billing NDC 68382077577
    Package 100 BLISTER PACK in 1 CARTON (68382-775-77) / 1 TABLET in 1 BLISTER PACK
    Marketing Start Date 2017-02-09
    NDC Exclude Flag N
    Pricing Information N/A